MED6 and hepatocellular carcinoma: The patients with HCC who had high expression levels of MED6, MED8, MED10, MED17, MED19, MED20, MED21, MED22, MED24, and MED25 were significantly associated with worse prognosis in terms of the key factors, OS and DFS.